Advanced Oncotherapy plc R3I1.F Stock
Advanced Oncotherapy plc Price Chart
Advanced Oncotherapy plc R3I1.F Financial and Trading Overview
| Advanced Oncotherapy plc stock price | 0.02 EUR |
| Previous Close | 0.04 EUR |
| Open | 0.03 EUR |
| Bid | 0.03 EUR x 0 |
| Ask | 0.06 EUR x 0 |
| Day's Range | 0.03 - 0.03 EUR |
| 52 Week Range | 0.02 - 0.3 EUR |
| Volume | 100 EUR |
| Avg. Volume | 1.74K EUR |
| Market Cap | 14.51M EUR |
| Beta (5Y Monthly) | 0.257471 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
R3I1.F Valuation Measures
| Enterprise Value | 82.32M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.19117646 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.287 |
Trading Information
Advanced Oncotherapy plc Stock Price History
| Beta (5Y Monthly) | 0.257471 |
| 52-Week Change | -81.55% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.3 EUR |
| 52 Week Low | 0.02 EUR |
| 50-Day Moving Average | 0.05 EUR |
| 200-Day Moving Average | 0.14 EUR |
R3I1.F Share Statistics
| Avg. Volume (3 month) | 1.74K EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 538.44M |
| Float | 208.29M |
| Short Ratio | N/A |
| % Held by Insiders | 40.25% |
| % Held by Institutions | 25.22% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -11.73% |
| Return on Equity (ttm) | -67.33% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -25048378 EUR |
| Net Income Avi to Common (ttm) | -32604732 EUR |
| Diluted EPS (ttm) | -0.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.51M EUR |
| Total Cash Per Share (mrq) | 0.005 EUR |
| Total Debt (mrq) | 59.74M EUR |
| Total Debt/Equity (mrq) | 98.71 EUR |
| Current Ratio (mrq) | 1.263 |
| Book Value Per Share (mrq) | 0.136 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26650056 EUR |
| Levered Free Cash Flow (ttm) | -34956660 EUR |
Profile of Advanced Oncotherapy plc
| Country | Germany |
| State | N/A |
| City | London |
| Address | 4 Tenterden Street |
| ZIP | W1S 1TE |
| Phone | 44 20 3617 8728 |
| Website | https://www.avoplc.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 174 |
Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
Q&A For Advanced Oncotherapy plc Stock
What is a current R3I1.F stock price?
Advanced Oncotherapy plc R3I1.F stock price today per share is 0.02 EUR.
How to purchase Advanced Oncotherapy plc stock?
You can buy R3I1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Advanced Oncotherapy plc?
The stock symbol or ticker of Advanced Oncotherapy plc is R3I1.F.
Which industry does the Advanced Oncotherapy plc company belong to?
The Advanced Oncotherapy plc industry is Medical Devices.
How many shares does Advanced Oncotherapy plc have in circulation?
The max supply of Advanced Oncotherapy plc shares is 560.05M.
What is Advanced Oncotherapy plc Price to Earnings Ratio (PE Ratio)?
Advanced Oncotherapy plc PE Ratio is now.
What was Advanced Oncotherapy plc earnings per share over the trailing 12 months (TTM)?
Advanced Oncotherapy plc EPS is -0.09 EUR over the trailing 12 months.
Which sector does the Advanced Oncotherapy plc company belong to?
The Advanced Oncotherapy plc sector is Healthcare.